Relationship between non-alcoholic fatty liver disease, metabolic syndrome and insulin resistance in Korean adults: A cross-sectional study

Clinica Chimica Acta

Volumn 458, Issue , 2016, Pages 12-17

  Kim, Ji Young ^a   Lee, Choae ^a   Oh, Minsuk ^a   Im, Jee Aee ^b   Lee, Ji Won ^c   Chu, Sang Hui ^a   Lee, Hyangkyu ^a   Jeon, Justin Y ^a  

^a Yonsei University   (South Korea)

^b INTOTO Inc   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Insulin resistance; Metabolic syndrome; Non alcoholic fatty liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL;

ADULT; AGE DISTRIBUTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; PREVALENCE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; ANALYSIS; BLOOD; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; SOUTH KOREA;

ADIPOSITY; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PREVALENCE; REPUBLIC OF KOREA;

EID: 84966318363     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2016.03.018     Document Type: Article

References (41)

1. Younossi Z.M., Stepanova M., Negro F., Hallaji S., Younossi Y., Lam B., et al. Nonalcoholic fatty liver disease in lean individuals in the United States. Med 2012, 91:319-327.
2. Amarapurkar D., Kamani P., Patel N., Gupte P., Kumar P., Agal S., et al. Ann. Hepatol. 2007, 6:161-163.
3. Shen L., Fan J.G., Shao Y., Zeng M.D., Wang J.R., Luo G.H., et al. Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey. World J. Gastroenterol. 2003, 9:1106-1110.
4. Younossi Z.M., Diehl A.M., Ong J.P. Nonalcoholic fatty liver disease: an agenda for clinical research. Hepatology 2002, 35:746-752.
5. Vernon G., Baranova A., Younossi Z.M. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment. Pharmacol. Ther. 2011, 34:274-285.
6. Huang H.L., Lin W.Y., Lee L.T., Wang H.H., Lee W.J., Huang K.C. Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects. Obes. Surg. 2007, 17:1457-1463.
7. Ong J.P., Elariny H., Collantes R., Younoszai A., Chandhoke V., Reines H.D., et al. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes. Surg. 2005, 15:310-315.
8. Colicchio P., Tarantino G., del Genio F., Sorrentino P., Saldalamacchia G., Finelli C., et al. Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy. Ann. Nutr. Metab. 2005, 49:289-295.
9. Beymer C., Kowdley K.V., Larson A., Edmonson P., Dellinger E.P., Flum D.R. Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery. Arch. Surg. 2003, 138:1240-1244.
10. Juarez-Rojas J.G., Medina-Urrutia A.X., Jorge-Galarza E., González-Salazar C., Kimura-Hayama E., Cardoso-Saldaña G., et al. Fatty liver increases the association of metabolic syndrome with diabetes and atherosclerosis. Diabetes Care 2013, 36:1726-1728.
11. Kwon Y.M., Oh S.W., Hwang S.S., Lee C.M. Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults. Am. J. Gastroenterol. 2012, 107:1852-1858.
12. Uchil D, Pipalia D, Chawla M, Patel R, Maniar S, Narayani, et al. Non-alcoholic fatty liver disease (NAFLD)-the hepatic component of metabolic syndrome. J. Assoc. Physicians India 2009; 57: 201-4.
13. Esteghamati A., Noshad S., Khalilzadeh O., Khalili M., Zandieh A., Nakhjavani M. Insulin resistance is independently associated with liver aminotransferases in diabetic patients without ultrasound signs of nonalcoholic fatty liver disease. Metab. Syndr. Relat. Disord. 2011, 9:111-117.
14. Bugianesi E., Moscatiello S., Ciaravella M.F., Marchesini G. Insulin resistance in nonalcoholic fatty liver disease. Curr. Pharm. Des. 2010, 16:1941-1951.
15. Wang X.F., Yue M. Relationship between alcohol consumption and clinical manifestation of patients with fatty liver: a single-center study. Hepatobiliary Pancreat. Dis. Int. 2011, 10:276-279.
16. World health Organization Measuring obesity-classification and description of anthropometric data. Report on a WHO Consultation of the Epidemiology of Obesity 1989, 123. WHO, Copenhagen, Warsaw 21-23 October 1987. Nutrition Unit document, EUR/ICP/NUT. 1987.
17. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18:499-502.
18. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
19. Hamaguchi M., Kojima T., Itoh Y., Harano Y., Fujii K., Nakajima T., Kawahito Y. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am. J. Gastroenterol. 2007, 102:2708-2715.
20. Scatarige J.C., Scott W.W., Donovan P.J., Siegelman S.S., Sanders R.C. Fatty infiltration of the liver: ultrasonographic and computed tomographic correlation. J. Ultrasound Med.: Off. J. Am. Inst. Ultrasound Med. 1984, 3:9-14.
21. Expert Panel on Detection E Treatment of High Blood Cholesterol in A. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
22. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752.
23. Oh S.W. Obesity and metabolic syndrome in Korea. Diabetes Metab. J. 2011, 35:561-566.
24. Marchesini G., Brizi M., Morselli-Labate A.M., Bianchi G., Bugianesi E., McCullough A.J., et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am. J. Med. 1999, 107:450-455.
25. Kotronen A., Seppala-Lindroos A., Bergholm R., Yki-Jarvinen H. Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome. Diabetologia 2008, 51:130-138.
26. Bugianesi E., Marchesini G., Gentilcore E., Cua I.H., Vanni E., Rizzetto M., et al. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: role of insulin resistance and hepatic steatosis. Hepatology 2006, 44:1648-1655.
27. van der Poorten D., Milner K.L., Hui J., Hodge A., Trenell M.I., Kench J.G., et al. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology 2008, 48:449-457.
28. Tchernof A., Despres J.P. Pathophysiology of human visceral obesity: an update. Physiol. Rev. 2013, 93:359-404.
29. Stefan N., Haring H.U. The role of hepatokines in metabolism. Nat. Rev. Endocrinol. 2013, 9:144-152.
30. Park S.H., Jeon W.K., Kim S.H., Kim H.J., Park D.I., Cho Y.K., et al. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J. Gastroenterol. Hepatol. 2006, 21:138-143.
31. Volzke H., Schwarz S., Baumeister S.E., Wallaschofski H., Schwahn C., Grabe H.J., et al. Menopausal status and hepatic steatosis in a general female population. Gut 2007, 56:594-595.
32. Janssen I., Heymsfield S.B., Wang Z., Ross R. Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J. Appl. Physiol. 2000, 89:81-88.
33. Pedersen B.K., Febbraio M.A. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol. 2012, 8:457-465.
34. Marchesini G., Bugianesi E., Forlani G., Cerrelli F., Lenzi M., Manini R., Rizzetto M. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003, 37:917-923.
35. Angelico F., Del Ben M., Conti R., Francioso S., Feole K., Fiorello S., Violi F. Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. J. Clin. Endocrinol. Metab. 2005, 90:1578-1582.
36. Farrell G.C., Wong V.W., Chitturi S. NAFLD in Asia-as common and important as in the West. Nat. Rev. Gastroenterol. Hepatol. 2013, 10:307-318.
37. Kim H.J., Kim H.J., Lee K.E., Kim D.J., Kim S.K., Ahn C.W., Lim S.K., Kim K.R., Lee H.C., Huh K.B., Cha B.S. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch. Intern. Med. 2004, 164:2169-2175.
38. Pagadala M.R., McCullough A.J. Non-alcoholic fatty liver disease and obesity: not all about body mass index. Am. J. Gastroenterol. 2012, 107:1859-1861.
39. Conus F., Allison D.B., Rabasa-Lhoret R., et al. Metabolic and behavioral characteristics of metabolically obese but normal-weight women. J. Clin. Endocrinol. Metab. 2004, 89:5013-5020.
40. 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur. Radiol. 2011, 21:87-97.
41. Kim S.H., Lee J.W., Im J.A., Hwang H.J. Increased gamma-glutamyltransferase and decreased total bilirubin are associated with metabolic syndrome in Korean postmenopausal women. Clin. Chem. Lab. Med. 2010, 48:1623-1628.